Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Sutro biopharma, inc. crawled time : 17:00 save search
BioNova Announces First Patient Dosed in a Phase 1/2 Study of BN301 for the Treatment of Hematologic Malignancies in China
Published: 2023-02-13 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: -0.31%
H: 8.62%
C: -1.88%
bn301 treatment china study phase 1
Vaxcyte Provides Positive Regulatory Updates for VAX-24 Adult and Pediatric Programs
Published: 2022-08-04 (Crawled : 17:00) - biospace.com/
PPRUF | News | $340.0 -6.66% 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 0.0%
H: 5.96%
C: 2.52%
PPRUY | News | $33.79 -8.58% -0.11% 360K
|
Manufacturing
|
| O: 0.04%
H: 1.21%
C: 0.78%
PCVX | $60.88 -1.17% -1.17% 670K
|
Health Technology
|
| O: 1.43%
H: 3.54%
C: 3.14%
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 1.68%
H: 1.28%
C: 0.55%
vax-24 positive
American Association for Cancer Research (AACR) Annual Meeting 2022 – Presentation
Published: 2022-04-08 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: -0.93%
H: 1.99%
C: -1.05%
research presentation cancer
Sutro Biopharma Presents Nonclinical Data for Antibody-Drug Conjugate STRO-002 at the AACR Annual Meeting 2022
Published: 2022-04-08 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: -0.93%
H: 1.99%
C: -1.05%
stro-002 biopharma drug antibody
63rd American Society of Hematology (ASH) Annual Meeting and Exposition – Non-Audio Presentation
Published: 2022-01-11 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 3.6%
H: 0.0%
C: 0.0%
Scientist, Protein LCMS Analysis (South San Fiasco, CA)
Published: 2021-10-21 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 0.38%
H: 1.13%
C: 0.91%
Scientist, Cell Biology (South San Francisco, CA)
Published: 2021-10-21 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 0.38%
H: 1.13%
C: 0.91%
Scientist, Analytical & Formulation Development (South San Francisco, CA)
Published: 2021-10-21 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 0.38%
H: 1.13%
C: 0.91%
Manufacturing Associate (San Carlos, CA)
Published: 2021-10-21 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 0.38%
H: 1.13%
C: 0.91%
Facilities Mechanic, R&D Site (South San Francisco, CA)
Published: 2021-10-21 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 0.38%
H: 1.13%
C: 0.91%
Director, Safety Assessment (South San Francisco, CA)
Published: 2021-10-21 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 0.38%
H: 1.13%
C: 0.91%
Contract Manufacturing Associate (South San Francisco, CA)
Published: 2021-10-21 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 0.38%
H: 1.13%
C: 0.91%
contract
Contract Business Applications Project Manager (South San Francisco, CA)
Published: 2021-10-21 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 0.38%
H: 1.13%
C: 0.91%
application contract
Business Applications Administrator (South San Francisco, CA)
Published: 2021-10-21 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 0.38%
H: 1.13%
C: 0.91%
application
Associate Director, Quality Control Analytical (San Carlos, CA)
Published: 2021-10-21 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 0.38%
H: 1.13%
C: 0.91%
Business Applications Administrator
Published: 2021-09-29 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -2.25%
application
Contract Business Applications Project Manager
Published: 2021-09-29 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -2.25%
contract application
Senior Buyer Planner
Published: 2021-07-09 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: -0.05%
H: 2.64%
C: -1.62%
Bill Newell, CEO Interviewed by Peter Hofland of The Onco’Zine Brief – “Antibody-Drug Conjugates: Coming of Age”
Published: 2021-06-24 (Crawled : 17:00) - sutrobio.com
STRO | $3.72 -1.33% -1.07% 720K
|
Health Technology
|
| O: 1.24%
H: 3.19%
C: 2.02%
antibody drug ceo
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
AGBA | $2.97 137.6% 54.87% 66M
|
Finance
HKIT | $1.33 30.39% 27.14% 39K
|
Technology Services
VRT 4 | $79.17 4.08% 19.36% 6.6M
|
Electronic Technology
FOA 4 | $0.5144 -8.16% 15.43% 20
|
Finance and Insurance
EAST | $1.0835 16.17% 15.21% 100
|
Commercial Services
BOF | $1.17 6.36% 14.73% 15K
|
TSLA | News | $144.68 1.85% 9.01% 93M
|
Consumer Durables
BNED | $0.2064 2.64% 8.96% 1.4M
|
Retail Trade
HLTH | $0.15 6.38% 7.84% 21K
|
LRN 4 | $58.2 0.17% 7.56% 950K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.